Challenger receives buyout offer worth $11.80 per share

Full story: https://grafa.com/en/news/australia/challenger-receives-buyout-offer-worth-11-80-per-share

Challenger received a non-binding acquisition offer to purchase all remaining ordinary shares.
The cash offer of $11.80 per share represents a 17.7% premium over the one-month volume-weighted average price of $10.03.
TAL Dai-ichi Life Australia aims to expand its ownership from 20.5% to 100% via a scheme of arrangement.

Challenger (ASX:CGF) has received a non-binding indicative takeover proposal from TAL Dai-ichi Life Australia to acquire the remaining 79.5% of ordinary shares it does not already own at $11.80 per share.

The proposed acquisition price of $11.80 per share represents a 17.7% premium compared to the company's one-month volume-weighted average price of $10.03.

The company stated that the board of Challenger is currently considering the indicative proposal while advising shareholders that no action is required and there is no certainty a binding deal will eventuate.

The transaction remains subject to several conditions, including the satisfactory completion of due diligence, formal agreement on acceptable terms, regulatory approvals, and a final board recommendation.

Following the announcement, the Challenger share price was unchanged at $9.85.

Founded in 1985, the company operates an APRA-regulated life insurance business focused on converting accumulated savings into retirement income.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":619924367417688,"tweetId":"619924367417688","gmtCreate":1792379336782,"gmtModify":1792379344047,"author":{"id":4169784042383112,"idStr":"4169784042383112","authorId":4169784042383112,"authorIdStr":"4169784042383112","name":"Grafa","avatar":"https://community-static.tradeup.com/news/ec1614006170d0aa3182195a94e8944d","vip":2,"userType":2,"introduction":"Grafa generates AI-driven data, news and analysis about NYSE, Nasdaq and ASX stocks","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":256,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://community-static.tradeup.com/news/51e7fb2e1bdbf7ad432ea1633caecec6","width":"1920","height":"1080"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/51e7fb2e1bdbf7ad432ea1633caecec6","width":"1920","height":"1080"}],"title":"Challenger receives buyout offer worth $11.80 per share","html":"<html><head></head><body><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/51e7fb2e1bdbf7ad432ea1633caecec6\" tg-width=\"1920\" tg-height=\"1080\"></p>\n<p>Full story: https://grafa.com/en/news/australia/challenger-receives-buyout-offer-worth-11-80-per-share</p>\n<ul>\n <li>\n  <p>Challenger received a non-binding acquisition offer to purchase all remaining ordinary shares.</p></li>\n <li>\n  <p>The cash offer of $11.80 per share represents a 17.7% premium over the one-month volume-weighted average price of $10.03.</p></li>\n <li>\n  <p>TAL Dai-ichi Life Australia aims to expand its ownership from 20.5% to 100% via a scheme of arrangement.</p></li>\n</ul>\n<p style=\"text-align: start;\">Challenger (ASX:CGF) has received a non-binding indicative takeover proposal from TAL Dai-ichi Life Australia to acquire the remaining 79.5% of ordinary shares it does not already own at $11.80 per share.</p>\n<p style=\"text-align: start;\">The proposed acquisition price of $11.80 per share represents a 17.7% premium compared to the company's one-month volume-weighted average price of $10.03.</p>\n<p style=\"text-align: start;\">The company stated that the board of Challenger is currently considering the indicative proposal while advising shareholders that no action is required and there is no certainty a binding deal will eventuate.</p>\n<p style=\"text-align: start;\">The transaction remains subject to several conditions, including the satisfactory completion of due diligence, formal agreement on acceptable terms, regulatory approvals, and a final board recommendation.</p>\n<p style=\"text-align: start;\">Following the announcement, the Challenger share price was unchanged at $9.85.</p>\n<p style=\"text-align: start;\">Founded in 1985, the company operates an APRA-regulated life insurance business focused on converting accumulated savings into retirement income.</p></body></html>","htmlText":"<html><head></head><body><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/51e7fb2e1bdbf7ad432ea1633caecec6\" tg-width=\"1920\" tg-height=\"1080\"></p>\n<p>Full story: https://grafa.com/en/news/australia/challenger-receives-buyout-offer-worth-11-80-per-share</p>\n<ul>\n <li>\n  <p>Challenger received a non-binding acquisition offer to purchase all remaining ordinary shares.</p></li>\n <li>\n  <p>The cash offer of $11.80 per share represents a 17.7% premium over the one-month volume-weighted average price of $10.03.</p></li>\n <li>\n  <p>TAL Dai-ichi Life Australia aims to expand its ownership from 20.5% to 100% via a scheme of arrangement.</p></li>\n</ul>\n<p style=\"text-align: start;\">Challenger (ASX:CGF) has received a non-binding indicative takeover proposal from TAL Dai-ichi Life Australia to acquire the remaining 79.5% of ordinary shares it does not already own at $11.80 per share.</p>\n<p style=\"text-align: start;\">The proposed acquisition price of $11.80 per share represents a 17.7% premium compared to the company's one-month volume-weighted average price of $10.03.</p>\n<p style=\"text-align: start;\">The company stated that the board of Challenger is currently considering the indicative proposal while advising shareholders that no action is required and there is no certainty a binding deal will eventuate.</p>\n<p style=\"text-align: start;\">The transaction remains subject to several conditions, including the satisfactory completion of due diligence, formal agreement on acceptable terms, regulatory approvals, and a final board recommendation.</p>\n<p style=\"text-align: start;\">Following the announcement, the Challenger share price was unchanged at $9.85.</p>\n<p style=\"text-align: start;\">Founded in 1985, the company operates an APRA-regulated life insurance business focused on converting accumulated savings into retirement income.</p></body></html>","text":"Full story: https://grafa.com/en/news/australia/challenger-receives-buyout-offer-worth-11-80-per-share Challenger received a non-binding acquisition offer to purchase all remaining ordinary shares. The cash offer of $11.80 per share represents a 17.7% premium over the one-month volume-weighted average price of $10.03. TAL Dai-ichi Life Australia aims to expand its ownership from 20.5% to 100% via a scheme of arrangement. Challenger (ASX:CGF) has received a non-binding indicative takeover proposal from TAL Dai-ichi Life Australia to acquire the remaining 79.5% of ordinary shares it does not already own at $11.80 per share. The proposed acquisition price of $11.80 per share represents a 17.7% premium compared to the company's one-month volume-weighted average price of $10.03. The company stated that the board of Challenger is currently considering the indicative proposal while advising shareholders that no action is required and there is no certainty a binding deal will eventuate. The transaction remains subject to several conditions, including the satisfactory completion of due diligence, formal agreement on acceptable terms, regulatory approvals, and a final board recommendation. Following the announcement, the Challenger share price was unchanged at $9.85. Founded in 1985, the company operates an APRA-regulated life insurance business focused on converting accumulated savings into retirement income.","highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/619924367417688","repostId":0,"isVote":1,"tweetType":1,"viewCount":2,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":1231,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/619924367417688"}